Japan's Shionogi creating coronavirus vaccine using insects

Drugmaker aims for trials this year with eventual goal of 10 million doses

Japanese drugmaker Shionogi is working with the National Institute of Infectious Diseases to develop a coronavirus vaccine, with the help of insects. It hopes to begin clinical trials later this year. (Source photo by Reuters)

Nikkei staff writers

April 27, 2020 20:55 JST

TOKYO -- Japanese drugmaker Shionogi & Co. said Monday that it is developing a coronavirus vaccine with the help of insects and aiming to start clinical trials this year.